A population-based observational study of restrictive guidelines for antibiotic therapy in early-onset neonatal infections

Pediatric Infectious Disease Journal

Volumn 26, Issue 7, 2007, Pages 593-599

  Labenne, Marc ^a   Michaut, Francis ^a   Gouyon, Béatrice ^a   Ferdynus, Cyril ^a   Gouyon, Jean Bernard ^a  

^a DIJON UNIVERSITY HOSPITAL   (France)

Author keywords

Antibiotic therapy; Early onset neonatal infection; Neonate; Preterm infant

Indexed keywords

AMIKACIN; AMOXICILLIN; ANTIBIOTIC AGENT; CEFOTAXIME; CEFUROXIME;

ANTIBIOTIC THERAPY; ARTICLE; ARTIFICIAL VENTILATION; BIRTH WEIGHT; CENTRAL VENOUS CATHETERIZATION; CLINICAL ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; FRANCE; HOSPITAL INFECTION; HUMAN; MALE; NEWBORN; NEWBORN INFECTION; OBSERVATIONAL STUDY; POPULATION RESEARCH; PRACTICE GUIDELINE; PRIORITY JOURNAL; RECURRENCE RISK; REINFECTION; RELAPSE; SEPTICEMIA; TREATMENT DURATION; TREATMENT OUTCOME;

AGE OF ONSET; ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; BIRTH WEIGHT; CATHETERIZATION, CENTRAL VENOUS; DRUG ADMINISTRATION SCHEDULE; HUMANS; INFANT, NEWBORN; ODDS RATIO; PRACTICE GUIDELINES; RESPIRATION, ARTIFICIAL; RISK FACTORS;

EID: 34347349135     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/INF.0b013e318068b656     Document Type: Article

References (40)

1. Spitzer AR, Kirkby S, Kornhauser M. Practice variation in suspected neonatal sepsis: a costly problem in neonatal intensive care. J Perinatol. 2005;25:265-269.
2. Escobar GJ. The neonatal "sepsis work-up": personal reflections on the development of an evidence-based approach toward newborn infections in a managed care organization. Pediatrics. 1999;103:360-373.
3. Baker CJ, Edwards MS. Group B streptococcal infections. In: Remington JS, Klein JO, eds. Infectious Diseases of the Fetus and Newborn Infant. 4th ed. Philadelphia, PA: WB Saunders;1995:980-1054.
4. Gerdes JS. Diagnosis and management of bacterial infections in the neonate. Pediatr Clin North Am. 2004;51:939-959.
5. Benitz WE, Han MY, Madan A, Ramachandra P. Serial C reactive protein levels in the diagnostics of neonatal infection. Pediatrics. 1998;102:e41.
6. Bomela HN, Ballot DE, Cory BJ, Cooper PA. Use of C reactive protein to guide duration of empirical therapy in suspected early neonatal sepsis. Pediatr infect Dis J. 2000;19:531-535.
7. Spritzer AR, Van Kamp HJ, Dzoljic G, Sauer PJ. Five years of cefotaxime use in a neonatal care unit. Pediatr Infect Dis J. 1990;9:92-96.
8. Aujard Y. Antibiothérapie des infections materno-foetales. Ann Pediatr. 1991;38:539-543.
9. Sarlangue J. Infections bactériennes du nouveau-né. Diagnostic, principes du traitement, prévention. Rev Prat. 2001;51:1361-1368.
10. Bromberger P, Lawrence JM, Braun D, Saunders B, Contreras R, Pettiti DB. The influence of intrapartum antibiotics on the clinical spectrum of early-onset group B streptococcal infection in term infants. Pediatrics. 2000;106:244-250.
11. Bromiker R, Arad I, Peleg O, Preminger A, Engelhard D. Neonatal bacteremia: patterns of antibiotic resistance. Infect Control Hosp Epidemiol. 2001;12:767-770.
12. Hyde TB, Hilger TM, Reingold A, Farley MM, O'Brien KL, Schuchat A. Trends in incidence and antimicrobial resistance of early-onset sepsis: population-based surveillance in San Francisco and Atlanta. Pediatrics. 2002;110:690-695.
13. Schuchat A, Zywiki SS, Dinsmoor MJ, et al. Risk factors and opportunities for prevention of early-onset neonatal sepsis: a multicenter case-control study. Pediatrics. 2000;105:21-26.
14. Stoll BJ, Hansen N, Fanaroff AA, et al. Changes in pathogens causing early-onset sepsis in very-low-birth-weight infants. N Engl J Med. 2002;347:240-247.
15. Towers CV, Briggs GG. Antepartum use of antibiotics and early-onset neonatal sepsis: the next 4 years. Am J Obstet Gynecol. 2002;187:495-500.
16. Tullus K, Burman LG. Ecologic impact of ampicillin and cefuroxime in neonatal units. Lancet. 1989;1:1405-1407.
17. Lautenbach E, Baldus Patel J, Bilker WB, Edelstein PH, Fishman NO. Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes. Clin Infect Dis. 2001;32:1162-1171.
18. Cordero L, Rau R, Taylor D, Ayers LW. Enteric Gram-negative bacilli bloodstream infections: 17 years' experience in a neonatal intensive care unit. Am J Infect Control. 2004;32:189-195.
19. Jain A, Roy I, Gupta MK, Kumar M, Agarwal SK. Prevalence of extended-spectrum beta-lactamase producing Gram-negative bacteria in septicaemic neonates in a tertiary care hospital. J Med Microbiol. 2003;52:421-425.
20. Nambiar S, Singh N. Change in epidemiology of health-care-associated infections in a neonatal intensive care unit. Ped Infect Dis J. 2002;21:839-842.
21. Pessoa-Silva CL, Meurer Moreira B, Camara Almeida V, et al. Extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in a neonatal intensive care unit: risk factors for infection and colonization. J Hosp Infect. 2003;53:198-206.
22. Gould IM. A review of the role of antibiotic policies in the control of antibiotic resistance. J Antimicrob Chemother. 1999;43:459-465.
23. Isaacs D. Unnatural selection: reducing antibiotic resistance in neonatal units. Arch Dis Child Fetal Neonatal Ed. 2006;91:F72-F74.
24. Cornet B, Gouyon JB, Binquet C, Sagot P, Ferdynus C, Metral P. Evaluation régionale en périnatalité: mise en place d'un recueil continu d'indicateurs. Rev Epidemiol Sante Publique. 2001;49:583-593.
25. Agence Nationale d'Accréditation et d'Evaluation en Santé. Diagnostic et traitement curatif de l'infection bactérienne précoce du nouveau-né. Arch Pediatr. 2003;10:489-496.
26. Langhendries JP, Battisti O, Bertrand JM, et al. Adaptation in neonatology of the once-daily concept of aminoglycoside administration: evaluation of a dosing chart for amikacin in an intensive care unit. Biol Neonate. 1998;74:351-362.
27. Ehl S, Gering B, Bartmann P, Hogel J, Pohlandt F. C-reactive protein in a useful marker for guiding duration of antibiotic therapy in suspected néonatal bacterial infection. Pediatrics. 1997;99:216-221.
28. Philip AG, Mills PC. Use of C reactive protein in minimizing antibiotic exposure: experience with infants initially admitted to a well-baby nursery. Pediatrics. 2000;106:e4.
29. Horan TC, Gaynes RP. Surveillance of nosocomial infections. In: Mayhall CG, ed. Hospital Epidemiology and Infection Control. 3rd ed. Philadelphia, PA: Lippincott, Williams and Wilkins; 2004:1669-1702.
30. Griner PF, Maryewski RJ, Mushlin AL, Greenland P. Selection and interpretation of diagnostic tests and procedures: principles and applications. Ann Intern Med. 1981;94:553-600.
31. Pierce JR, Merenstein GB, Stocker JT. Immediate postmortem culutres in an intensive care nursery. Pediatr Infect Dis J. 1984;3:510-513.
32. Schelonka RL, Chai MK, Yoder BA, Ascher DP. Volume of blood required to detect common neonatal pathogens. J Pediatr. 1996;129:275-278.
33. Neal PR, Kleiman MB, Reynolds JK, Allen SD, Lemons JA, Yu PL. Volume of blood submitted for culture from neonates. J Clin Microbiol. 1986;24:353-356.
34. De Man P, Verhoeven BAN, Verbrugh HA, Vos MC, Van den Anker JN. An antibiotic policy to prevent emergence of resistant bacilli. Lancet. 2000;335:973-978.
35. Auriti C, Maccallini A, Di Liso G, Di Ciommo V, Ronchetti MP, Orzalesi M. Risk factors for nosocomial infections in a neonatal intensive care unit. J Hosp Infect. 2003;53:25-30.
36. Makhoul IR, Sujov P, Smolkin T, Lusky A, Reichman B. Epidemiological, clinical and microbiological characteristics of late-onset sepsis among very low birth weight infants in Israel: a national survey. Pediatrics. 2002;109:34-39.
37. Ronnestad A, Abrahamsen TG, Medbo S, et al. Late-onset septicemia in a Norwegian national cohort of premature infants receiving very early full human milk feeding. Pediatrics. 2005;115:e269.
38. Sohn AH, Garrett DO, Sinkowitz-Cochran RL, et al. Prevalence of nosocomial infections in neonatal intensive care unit patients: results from the first national point-prevalence survey. J Pediatr. 2001;139:821-827.
39. Stoll BJ, Hansen N, Fanaroff AA, et al. Late-onset sepsis in very low birth weight neonates: the experience of the NICHD neonatal research network. Pediatrics. 2002;110:285-291.
40. Singh N, Rogers P, Atwood CW, Wagener MM, Yu VL. Short-course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit. A proposed solution for indiscriminate antibiotic prescription. Am J Respir Crit Care Med. 2000;162:505-511.